NEMBUTAL Drug Patent Profile
✉ Email this page to a colleague
When do Nembutal patents expire, and what generic alternatives are available?
Nembutal is a drug marketed by Sciegen Pharms Inc, Epic Pharma Llc, and Rising. and is included in six NDAs.
The generic ingredient in NEMBUTAL is pentobarbital sodium. There are two drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the pentobarbital sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nembutal
A generic version of NEMBUTAL was approved as pentobarbital sodium by SAGENT PHARMS INC on May 23rd, 2016.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NEMBUTAL?
- What are the global sales for NEMBUTAL?
- What is Average Wholesale Price for NEMBUTAL?
Summary for NEMBUTAL
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 37 |
Clinical Trials: | 1 |
DailyMed Link: | NEMBUTAL at DailyMed |
Recent Clinical Trials for NEMBUTAL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Washington University School of Medicine | N/A |
US Patents and Regulatory Information for NEMBUTAL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sciegen Pharms Inc | NEMBUTAL | pentobarbital | ELIXIR;ORAL | 083244-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Epic Pharma Llc | NEMBUTAL SODIUM | pentobarbital sodium | CAPSULE;ORAL | 084093-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sciegen Pharms Inc | NEMBUTAL | pentobarbital sodium | SUPPOSITORY;RECTAL | 083247-003 | Jan 25, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Epic Pharma Llc | NEMBUTAL SODIUM | pentobarbital sodium | CAPSULE;ORAL | 083245-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |